CHINA PHARMA HOLDINGS, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses
CHINA PHARMA HOLDINGS, INC. (CPHI) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses of $6.75 thousand as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses · last filed 2024-04-01
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses $6.75K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses $6.79K.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses $8.05K.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses $6.82K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses |
|---|---|
| 2023-12-31 | $6.75K 10-K · filed 2024-04-01 |
| 2022-12-31 | $6.79K 10-K · filed 2024-04-01 |
| 2021-12-31 | $8.05K 10-K · filed 2023-03-30 |
| 2020-12-31 | $6.82K 10-K · filed 2022-03-30 |
| 2019-12-31 | $5.68K 10-K · filed 2021-03-26 |
| 2018-12-31 | $8.72K 10-K · filed 2020-03-30 |
| 2017-12-31 | $10.00K 10-K · filed 2019-03-28 |
| 2016-12-31 | $17.96K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |